Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CuraGen (CRGN) -- Ignore unavailable to you. Want to Upgrade?

To: AV8R who wrote (40)	11/18/1998 5:04:00 PM
From: TokyoMex	Read Replies (2) \| Respond to of 478

Let us hope for news all across America tonight .... At least WSJ or NY Times ,, I would like to see this open at 24 ,,like GERN did ..

To: AV8R who wrote (40)	11/20/1998 9:16:00 AM
From: TokyoMex	Respond to of 478

Yi Haaaaa !!! -------------------------------------------------------------------------------- > 11/20 7:02A (DJ) +Curagen, Glaxo Wellcome In Drug Discovery Collaboration > Story 1457 Curagen - Collaboration -2: To Identify Drug Candidates > NEW HAVEN, Conn. (Dow Jones)--CuraGen Corp. (CRGN) and Glaxo Wellcome Inc. > (GLX) formed a five-year drug discovery collaboration. > In a press release Friday, CuraGen said Glaxo Wellcome will use its > integrated genomics processes to study and select Glaxo Wellcome compounds for > clinical development. > CuraGen will evaluate compounds across Glaxo Wellcome's therapeutic > programs, identifying gene responses associated with compound efficacy and > toxicity. > The collaboration allows Glaxo Wellcome to select drug candidates with the > highest likelihood of success in clinical trials. > (END) DOW JONES NEWS 11-20-98 > 07:50 AM > Additional Codes (N/DSC, N/JVN, N/TEC, N/WEI, M/NCY, M/TEC, P/DEE, P/DPH, > R/CT, R/EU, R/NME, R/UK, R/US, R/USE, R/WEU) >